Alterity Therapeutics (ATHE) Other Gross PP&E Adjustments (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Other Gross PP&E Adjustments of -$65280.6 for Q4 2025, down 8.54% year-on-year from -$71374.2 in Q4 2024, and up 37.32% on a QoQ basis from -$104152.6 in Q2 2025.
Alterity Therapeutics (ATHE) Other Gross PP&E Adjustments (2009 - 2025) Analysis & Trends
Alterity Therapeutics (ATHE) has reported Other Gross PP&E Adjustments for 17 consecutive years, with -$65280.6 the latest figure, recorded in Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 8.54% year-over-year to -$65280.6 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$65280.6 (down 8.54% YoY) and the FY2025 annual result came in at -$104152.6, down 20.32% from the prior year.
- Other Gross PP&E Adjustments grew to -$65280.6 in Q4 2025 per ATHE's latest filing, from -$104152.6 in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for ATHE reached as high as $615.83 in Q4 2022 and fell as low as -$104152.6 in Q2 2025.
- A 5-year average of -$34645.1 and a median of -$16932.1 in 2021 frame the typical range for Other Gross PP&E Adjustments.
- Annual changes were most pronounced in 2022 — Other Gross PP&E Adjustments soared 106.33% — and 2023, when it sank 11705.16%.
- Year by year, Other Gross PP&E Adjustments stood at -$9724.0 in 2021, then jumped by 106.33% to $615.83 in 2022, then sank by 11705.16% to -$71467.8 in 2023, then increased by 15.84% to -$60145.6 in 2024, then fell by 8.54% to -$65280.6 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods registered -$65280.6, -$104152.6, and -$60145.6 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -3.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -1.69 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -67.74 Mn |
| 10 | Alterity Therapeutics | 30.00 Bn | 30.00 Bn | - | -65,280.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -65,280.58 |
| Dec 31, 2025 | -65,280.58 |
| Jun 30, 2025 | -104,152.60 |
| Jun 30, 2025 | -104,152.60 |
| Dec 31, 2024 | -60,145.62 |
| Dec 31, 2024 | -60,145.62 |
| Jun 30, 2024 | -1,225.75 |
| Jun 30, 2024 | -1,225.75 |
| Dec 31, 2023 | -71,467.82 |
| Dec 31, 2023 | -71,467.82 |
| Jun 30, 2023 | -1,453.11 |
| Jun 30, 2023 | -1,453.11 |
| Dec 31, 2022 | 615.83 |
| Dec 31, 2022 | 615.83 |
| Jun 30, 2022 | -9,477.54 |
| Jun 30, 2022 | -9,477.54 |
| Dec 31, 2021 | -9,724.01 |
| Dec 31, 2021 | -9,724.01 |
| Jun 30, 2021 | -24,140.17 |
| Jun 30, 2021 | -24,140.17 |